Maurizio Scaltriti

35PUBLICATIONS
222CO-AUTHORS
Predictive and prognostic markersMolecular targetsMathematical economicsCancer geneticsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Dec 18, 2025
Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis.

James Boyle, Jan Zaucha, Felicia Ng

|Dec 11, 2025
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

Srushti Kittane, Erik Ladewig, Taibo Li

|Jun 04, 2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

Yanyan Cai, Peihua Zhao, Fan Wu

|Jan 03, 2023
Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations.

Smruthy Sivakumar, Dexter X Jin, Ruchita Rathod

|Nov 14, 2022
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Marta Palafox, Laia Monserrat, Meritxell Bellet

|Sep 07, 2022
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Marta Palafox, Laia Monserrat, Meritxell Bellet

Pageof 6

Frequent Collaborators

8 joint publications

Eneda Toska

8 joint publications

Sarat Chandarlapaty

6 joint publications

Cristina Saura

5 joint publications

Pau Castel